ArticleBiomedicines2022

Clinical Feasibility Study of Gold Nanoparticles as Theragnostic Agents for Precision Radiotherapy.

José Antonio López-Valverde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.